Absci News - August 11, 2026
Absci Drops 10% After Earnings — Can an AI Drug Company With Almost No Revenue Justify a $1.4 Billion Valuation?
Shares shifted sharply as Absci Corp (ABSI) fell 10.2% to $8.45 the morning after releasing second-quarter 2026 results following market close on August 11....
Absci Corporation misses second quarter 2026 expectations while extending cash runway into late 2028
Absci reported second quarter 2026 revenue of $0.3 million and a net loss per share of $0.21, missing analyst estimates as the company prioritizes clinical...
🔴 Absci is trading 10.2% down in after-hours trading following a significant second-quarter revenue miss
Absci is trading at $8.45 (-10.20%) after its second-quarter earnings release. - The company reported Q2 2026 revenue of $0.3 million, significantly below...